Cargando…

Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue

BACKGROUND: Lactate dehydrogenase A (LDHA) and Pyruvate Kinase M2 (PKM2) are important enzymes of glycolysis. Both of them can be phosphorylated and therefore regulated by Fibroblast growth factor receptor 1 (FGFR1). While phosphorylation of LDHA at tyrosine10 leads to tetramerization and activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Kachel, Paul, Trojanowicz, Bogusz, Sekulla, Carsten, Prenzel, Hanna, Dralle, Henning, Hoang-Vu, Cuong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393606/
https://www.ncbi.nlm.nih.gov/pubmed/25880801
http://dx.doi.org/10.1186/s12885-015-1135-y
_version_ 1782366187814912000
author Kachel, Paul
Trojanowicz, Bogusz
Sekulla, Carsten
Prenzel, Hanna
Dralle, Henning
Hoang-Vu, Cuong
author_facet Kachel, Paul
Trojanowicz, Bogusz
Sekulla, Carsten
Prenzel, Hanna
Dralle, Henning
Hoang-Vu, Cuong
author_sort Kachel, Paul
collection PubMed
description BACKGROUND: Lactate dehydrogenase A (LDHA) and Pyruvate Kinase M2 (PKM2) are important enzymes of glycolysis. Both of them can be phosphorylated and therefore regulated by Fibroblast growth factor receptor 1 (FGFR1). While phosphorylation of LDHA at tyrosine10 leads to tetramerization and activation, phosphorylation of PKM2 at tyrosine105 promotes dimerization and inactivation. Dimeric PKM2 is found in the nucleus and regulates gene transcription. Up-regulation and phosphorylation of LDHA and PKM2 contribute to faster proliferation under hypoxic conditions and promote the Warburg effect. METHODS: Using western blot and SYBR Green Real time PCR we investigated 77 thyroid tissues including 19 goiter tissues, 11 follicular adenomas, 16 follicular carcinomas, 15 papillary thyroid carcinomas, and 16 undifferentiated thyroid carcinomas for total expression of PKM2, LDHA and FGFR1. Additionally, phosphorylation status of PKM2 and LDHA was analysed. Inhibition of FGFR was performed on FTC133 cells with SU-5402 and Dovitinib. RESULTS: All examined thyroid cancer subtypes overexpressed PKM2 as compared to goiter. LDHA was overexpressed in follicular and papillary thyroid cancer as compared to goiter. Elevated phosphorylation of LDHA and PKM2 was detectable in all analysed cancer subtypes. The highest relative phosphorylation levels of PKM2 and LDHA compared to overall expression were found in undifferentiated thyroid cancer. Inhibition of FGFR led to significantly decreased phosphorylation levels of PKM2 and LDHA. CONCLUSIONS: Our data shows that overexpression and increased phosphorylation of PKM2 and LHDA is a common finding in thyroid malignancies. Phospho-PKM2 and Phospho-LDHA could be valuable tumour markers for thyroglobulin negative thyroid cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1135-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4393606
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43936062015-04-12 Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue Kachel, Paul Trojanowicz, Bogusz Sekulla, Carsten Prenzel, Hanna Dralle, Henning Hoang-Vu, Cuong BMC Cancer Research Article BACKGROUND: Lactate dehydrogenase A (LDHA) and Pyruvate Kinase M2 (PKM2) are important enzymes of glycolysis. Both of them can be phosphorylated and therefore regulated by Fibroblast growth factor receptor 1 (FGFR1). While phosphorylation of LDHA at tyrosine10 leads to tetramerization and activation, phosphorylation of PKM2 at tyrosine105 promotes dimerization and inactivation. Dimeric PKM2 is found in the nucleus and regulates gene transcription. Up-regulation and phosphorylation of LDHA and PKM2 contribute to faster proliferation under hypoxic conditions and promote the Warburg effect. METHODS: Using western blot and SYBR Green Real time PCR we investigated 77 thyroid tissues including 19 goiter tissues, 11 follicular adenomas, 16 follicular carcinomas, 15 papillary thyroid carcinomas, and 16 undifferentiated thyroid carcinomas for total expression of PKM2, LDHA and FGFR1. Additionally, phosphorylation status of PKM2 and LDHA was analysed. Inhibition of FGFR was performed on FTC133 cells with SU-5402 and Dovitinib. RESULTS: All examined thyroid cancer subtypes overexpressed PKM2 as compared to goiter. LDHA was overexpressed in follicular and papillary thyroid cancer as compared to goiter. Elevated phosphorylation of LDHA and PKM2 was detectable in all analysed cancer subtypes. The highest relative phosphorylation levels of PKM2 and LDHA compared to overall expression were found in undifferentiated thyroid cancer. Inhibition of FGFR led to significantly decreased phosphorylation levels of PKM2 and LDHA. CONCLUSIONS: Our data shows that overexpression and increased phosphorylation of PKM2 and LHDA is a common finding in thyroid malignancies. Phospho-PKM2 and Phospho-LDHA could be valuable tumour markers for thyroglobulin negative thyroid cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1135-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-18 /pmc/articles/PMC4393606/ /pubmed/25880801 http://dx.doi.org/10.1186/s12885-015-1135-y Text en © Kachel et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kachel, Paul
Trojanowicz, Bogusz
Sekulla, Carsten
Prenzel, Hanna
Dralle, Henning
Hoang-Vu, Cuong
Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title_full Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title_fullStr Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title_full_unstemmed Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title_short Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
title_sort phosphorylation of pyruvate kinase m2 and lactate dehydrogenase a by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393606/
https://www.ncbi.nlm.nih.gov/pubmed/25880801
http://dx.doi.org/10.1186/s12885-015-1135-y
work_keys_str_mv AT kachelpaul phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue
AT trojanowiczbogusz phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue
AT sekullacarsten phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue
AT prenzelhanna phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue
AT drallehenning phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue
AT hoangvucuong phosphorylationofpyruvatekinasem2andlactatedehydrogenaseabyfibroblastgrowthfactorreceptor1inbenignandmalignantthyroidtissue